Literature DB >> 26710181

RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis.

Bing Liu1, Tuo Deng, Junjun Zhang.   

Abstract

PURPOSE: Central serous chorioretinopathy (CSC) is a common retina disease and has a relative high recurrence rate, etiology, and pathogenesis of which remains ambiguous. The systematic review and meta-analysis aimed to measure risk factors for CSC in a quantitative method, providing some precautions and interventions on this disease and preventing further recurrences.
METHODS: A comprehensive literature review relating to risk factors for CSC through PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), and VIP databases was conducted before March 2015. Odds ratio (OR) with 95% confidence interval (CI) was calculated after data combination to assess the associations between risk factors and CSC.
RESULTS: A total of 9839 patients in 17 studies were included and risk factors with significant differences found between CSC and control groups were listed as follows: hypertension (OR = 1.7; 95% CI: 1.28-2.25), Helicobacter pylori (H. pylori) infection (OR = 3.12; 95% CI: 1.81-5.40), steroid usage (OR = 4.29; 95% CI: 2.01-9.15), sleeping disturbance (OR = 1.90; 95% CI: 1.28-1.83), autoimmune disease (OR=3.44; 95% CI: 1.90-6.26), psychopharmacologic medication use (OR = 2.69; 95% CI: 1.63-4.45), and Type-A behavior (OR = 2.53; 95% CI: 1.08-5.96).
CONCLUSION: The authors concluded that hypertension, H. pylori infection, steroid usage, sleeping disturbance, autoimmune disease, psychopharmacologic medication use, and Type-A behavior were possible risk factors relating to the occurrence of CSC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26710181     DOI: 10.1097/IAE.0000000000000837

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  44 in total

Review 1.  [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

Review 2.  Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis.

Authors:  Shangli Ji; Yemei Wei; Jiansu Chen; Shibo Tang
Journal:  Int J Clin Pharm       Date:  2017-04-06

Review 3.  [Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].

Authors: 
Journal:  Ophthalmologe       Date:  2021-12-14       Impact factor: 1.059

4.  Mitochondrial DNA as a Biomarker for Acute Central Serous Chorioretinopathy: A Case-Control Study.

Authors:  Noriyasu Hashida; Kazunobu Asao; Chikako Hara; Andrew J Quantock; Ryotaro Saita; Hiroyuki Kurakami; Kazuichi Maruyama; Kohji Nishida
Journal:  Front Med (Lausanne)       Date:  2022-06-21

5.  Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.

Authors:  Bertan Cakir; Franziska Fischer; Christoph Ehlken; Anima Bühler; Andreas Stahl; Günther Schlunck; Daniel Böhringer; Hansjürgen Agostini; Clemens Lange
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-05       Impact factor: 3.117

6.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

7.  Comments to the Editor concerning the paper entitled "The microbiome and ophthalmic disease" by Baim et al.

Authors:  Michael Doulberis; Stergios A Polyzos; Apostolis Papaefthymiou; Panagiotis Katsinelos; Jannis Kountouras
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-17

Review 8.  [Central serous chorioretinopathy].

Authors:  Laurenz Pauleikhoff; Hansjürgen Agostini; Clemens Lange
Journal:  Ophthalmologe       Date:  2021-04-16       Impact factor: 1.059

Review 9.  Alcohol and the Eye.

Authors:  Saeed Karimi; Amir Arabi; Toktam Shahraki
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

Review 10.  Central Serous Chorioretinopathy and Personality Characteristics: A Systematic Review of Scientific Evidence over the Last 10 Years (2010 to 2020).

Authors:  Giovanni Genovese; Alessandro Meduri; Maria Rosaria Anna Muscatello; Sebastiano Gangemi; Clemente Cedro; Antonio Bruno; Pasquale Aragona; Gianluca Pandolfo
Journal:  Medicina (Kaunas)       Date:  2021-06-16       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.